EcoDrugPlus

Gamma-Aminobutyric Acid Type A Receptor Subunit Gamma3

Ensembl ID : ENSSMAG00000020062
Gene Symbol: GABRG3
3 Cross references
215 Possible Orthologues:

Gastric Inhibitory Polypeptide Receptor

Ensembl ID : ENSSMAG00000020380
Gene Symbol: GIPR
2 Cross references
164 Possible Orthologues:

General Transcription Factor Iiia, B

Ensembl ID : ENSSMAG00000014422
Gene Symbol: GTF3AB
3 Cross references
784 Possible Orthologues:

Glucagon Like Peptide 2 Receptor

Ensembl ID : ENSSMAG00000002937
Gene Symbol: GLP2R
3 Cross references
204 Possible Orthologues:

Glucokinase (Hexokinase 4)

Ensembl ID : ENSSMAG00000007420
Gene Symbol: GCK
2 Cross references
211 Possible Orthologues:

Glucosidase, Alpha; Acid (Pompe Disease, Glycogen Storage Disease Type Ii)

Ensembl ID : ENSSMAG00000014997
Gene Symbol: GAA
2 Cross references
234 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 1

Ensembl ID : ENSSMAG00000003567
Gene Symbol: GRIK1
3 Cross references
248 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSSMAG00000013069
Gene Symbol: GRIK2
1 Cross references
246 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 3

Ensembl ID : ENSSMAG00000005100
Gene Symbol: GRIK3
1 Cross references
256 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSSMAG00000015732
Gene Symbol: GRIK4
3 Cross references
248 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSSMAG00000013443
Gene Symbol: LOC118312962
2 Cross references
242 Possible Orthologues:

Glutamate Receptor, Ionotropic, Ampa 1a

Ensembl ID : ENSSMAG00000009591
Gene Symbol: GRIA1A
1 Cross references
251 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).